dormorna glp 1 ✨ NEW WEIGHT LOSS OPTION ALERT ✨ There's a new option entering the weight management space — Lilly's oral GLP-1 tablet (Foundayo™ / orforglipron). Unlike injectable GLP-1 medications, this is a once-daily New GLP-1 Pill Foundayo (Orforglipron)

Its promise, according to Dr Levi Garraway, PhD, Roches Chief Medical Officer and Head of Global Product Development, results from the robust weight loss combined with a well-tolerated safety profile. Furthermore, at the end of last year, Pfizer paid a $2 billion for China-based manufacturer YaoPharmas GLP-1 drug, increasing competition in the expanding market, while in August Teva secured US approval for a generic GLP-1 of its version of Novo Nordisks injectable Saxenda (liraglutide).

doi:10.3389/falgy.2026.1777688 2

Durable and effective, its made to withstand daily use and deliver consistent results

Research-use-only disclaimer

Think of glutathione as a rechargeable battery

As the research on peptides evolves, so will the information in this guide